Baseline prostate inflammation is associated with a reduced risk of prostate cancer in men undergoing repeat prostate biopsy: Results from the REDUCE study

By  

CANCER, Vol. 120, Iss. 2, 2014-01 ,pp. : 190-196

John Wiley & Sons Inc

Access to resources Recommend Favorite

Moreira DM, Nickel JC, Gerber L, Muller RL, Andriole GL, Castro‐Santamaria R and Freedland SJ. Baseline prostate inflammation is associated with a reduced risk of prostate cancer in men undergoing repeat prostate biopsy: Results from the REDUCE study. Cancer. 2014;120:190‐196.

By  

CANCER, Vol. 121, Iss. 23, 2015-12 ,pp. : 4271-4271

John Wiley & Sons Inc

Access to resources Recommend Favorite

Metabolic syndrome‐like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study

By  

BJU INTERNATIONAL, Vol. 115, Iss. 5, 2015-05 ,pp. : 736-743

John Wiley & Sons Inc

Access to resources Recommend Favorite

Decisional conflict in economically disadvantaged men with newly diagnosed prostate cancer: Baseline results from a shared decision‐making trial

By  

CANCER, Vol. 120, Iss. 17, 2014-09 ,pp. : 2721-2727

John Wiley & Sons Inc

Access to resources Recommend Favorite

Chronic Inflammation in Prostate Biopsy Cores is an Independent Factor that Lowers the Risk of Prostate Cancer Detection and is Inversely Associated with the Number of Positive Cores in Patients Elected to a First Biopsy

By  

Current Urology, Vol. 9, Iss. 2, 2016-05 ,pp. : 82-92

Karger

Access to resources Recommend Favorite